New data suggests early risk from Vioxx
New data indicates that Vioxx may be most dangerous to patients three to four months after they start taking the medicine. Researchers had earlier estimated that the cardiovascular risks associated with Vioxx rose after 18 months of use, according to a report in The Wall Street Journal. The new analysis is based on a follow-up study of data gathered in earlier studies. Vioxx was removed from the market in 2004.
- read the CNN report on Vioxx
ALSO: A group of shareholders lawsuits claiming that Merck executives had violated their duties by hiding the health risk of Vioxx has been dismissed due to a procedural issue. Report
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
